Accumulated Other Comprehensive Income (Loss), Net of Tax of Akso Health Group from 31 Mar 2017 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Summary
Akso Health Group quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax in USD history and change rate from 31 Mar 2017 to 31 Mar 2025.
  • Akso Health Group Accumulated Other Comprehensive Income (Loss), Net of Tax for the quarter ending 31 Mar 2025 was $3,771,374, a 7.7% increase year-over-year.
Source SEC data
View on sec.gov
Accumulated Other Comprehensive Income (Loss), Net of Tax, Quarterly (USD)
Accumulated Other Comprehensive Income (Loss), Net of Tax, YoY Quarterly Change (%)

Akso Health Group Quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,771,374 +$315,213 +7.7% 31 Mar 2025 20-F 14 Aug 2025 2025 FY
Q3 2024 $4,060,547 -$168,707 -4.3% 30 Sep 2024 6-K 28 Mar 2025 2025 Q2
Q1 2024 $4,086,587 -$238,986 -6.2% 31 Mar 2024 20-F 14 Aug 2025 2025 FY
Q3 2023 $3,891,840 +$938,482 +19% 30 Sep 2023 6-K 03 Jan 2024 2024 Q2
Q1 2023 $3,847,601 -$2,198,378 -133% 31 Mar 2023 20-F 30 Jul 2024 2024 FY
Q3 2022 $4,830,322 30 Sep 2022 6-K 16 Feb 2023 2023 Q2
Q1 2022 $1,649,223 +$1,454,320 +47% 31 Mar 2022 20-F 14 Jul 2023 2023 FY
Q1 2021 $3,103,543 +$3,942,157 +56% 31 Mar 2021 20-F 29 Dec 2022 2022 FY
Q1 2020 $7,045,700 -$5,288,742 -301% 31 Mar 2020 20-F 28 Jul 2021 2021 FY
Q1 2019 $1,756,958 -$6,136,187 -140% 31 Mar 2019 20-F 14 Aug 2020 2020 FY
Q1 2018 $4,379,229 +$5,923,982 31 Mar 2018 20-F 31 Jul 2019 2019 FY
Q1 2017 $1,544,753 31 Mar 2017 20-F 30 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.